Methods for detecting cellular pathology by assaying spectrin an

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 4, 436501, 436811, 436174, C12Q 100, G01N 3353, G01N 33566, G01N 2400

Patent

active

051186063

ABSTRACT:
The invention provides a method for the detection of cellular pathology by means of an immunoassay to determine the presence of stable breakdown products, termed BDP's or BDP1 and BDP2, of the cytoskeleton component spectrin. In one aspect of the invention, the components from a sample of spectrin-containing cells are physically separated, as by exposure to an electric field, in such a way that BDP and spectrin are separated. Antibodies reactive with BDP are then contacted with the separated sample, and their binding to that portion of the sample containing any BDP determined. In another aspect of the invention, an assay, such as an ELISA assay, is performed to detect total spectrin immunoreactivity as an indication of cellular death or degradation.

REFERENCES:
Siman et al., Brain fodrin: Substrate for calpain I, an endogenous calcium-activated protease, Proc. Natl. Acad. Sci. USA 81:3572-3576 (1984).
Seubert et al., Calmodulin Stimulates the Degradation of Brain Spectrin by Calpain, Synapse 1:20-24 (1987).
Harris et al., Mechanism of cytoskeletal regulation (I): functional differences correlate with antigenic dissimilarity in human brain and erythrocyte spectrin, Biophysica Acta 830:147-158 (1985).
Fox et al., Spectrin is Associated with Membrane-Bound Actin Filaments in Platelets and is Hydrolyzed by the Ca.sup.2+ -Dependent Protease During Platelet Activation, Blood 69:537-545 (1987).
Glenney et al., Erythroid spectrin, brain fodrin, and intestinal brush border proteins (TW-260/240) are related molecules containing a common calmodulin-binding subunit bound to a variant cell type-specific subunit, Proc. Natl. Acad. Sci. USA 79:4002-4005 (1982).
Jonathan Davis and Vann Bennett, Brain Spectrin Isolation of Subunits and Formation of Hybrids with Erythrocyte Spectrin Subunits, The Journal of Biological Chemistry 258:7757-7766 (1983).
Tadashi Yamashita, Changes in Brain Proteins Following Transient Ischemia in Mongolian Gerbils, Dept. of Neuropsychiatry, Osaka Univ. Med. School.
Siman et al., Calpain I Activation is Specifically Related to Excitatory Amino Acid Induction of Hippocampal Damage, The Journal of Neuroscience 9(5):1579-1590 (1989).
Seubert et al., Lesions of entorhinal cortex produce a calpain-mediated degradation of brain spectrin in dentate gyrus, Brain Research 459:226-232 (1988).
Kuwaki et al., Nilvadipine Attenuates Ischemic Degradation of Gerbil Brain Cytoskeletal Proteins, Stroke 20:78-83 (1989).
Seubert et al., Intrahippocampal Colchicine Injection Results in Spectrin Proteolysis, Neuroscience 31:195-202 (1989).
Seubert et al., Stimulation of NMDA receptors induces proteolysis of spectrin in hippocampus, Brain Research 460:189-194 (1988).
Takashi Murachi, Introcellular Regulatory System Involving Calpain and Calpastatin, Biochemistry International 18:263-294 (1989).
Siman, R. and Noszek, J., Excitatory Amino Acids Activate Calpain I and Induce Structural Protein Breakdown In Vivo, Neuron 1:279-287 (1988).
Groome et al., A new epitope on human myelin basic protein arising from cleavage by a metalloendoprotease associated with brain myelin membranes, Journal of Neuroimmunology 19:77-88 (1988).
Appleyard et al., "Monoclonal Antibodies Detect a Spectrin-Like Protein in Normal and Dystrophic Human Skeletal Muscle", Proc. Natl. Acad. Sci. USA (1984), vol. 81, 776-780.
Arduini et al., "Spectrin Degradation in Intact Red Blood Cells by Phenylhydrazine", Biochemical Pharmacolog. (1985) 4283-4289.
Davis et al., 1983, Brain Spectrin, J. Biol. Chem. 256: 7757-7766.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods for detecting cellular pathology by assaying spectrin an does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for detecting cellular pathology by assaying spectrin an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for detecting cellular pathology by assaying spectrin an will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2227944

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.